Bruderman Asset Management’s Microbot Medical MBOT Stock Holding History

Bruderman Asset Management’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2	Closed	–	–	373
2019 Q1	$0	Hold	2	–	–	﹤0.01%	674
2018 Q4	$0	Buy	+2	New	+$8	﹤0.01%	673

Other funds holding MBOT

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bruderman Asset Management's MBOT Position: Q2 2019 in Review

Bruderman Asset Management sold out of Microbot Medical (MBOT) in Q2 2019, closing a stake of 2 shares.

Bruderman Asset Management first reported a position in MBOT in Q4 2018 and held it in 2 quarters. The position peaked at $0 in Q1 2019. 30 funds tracked by Wall St. Rank hold MBOT as of Q2 2019.

Bruderman Asset Management reported no remaining Microbot Medical position as of Q2 2019 after selling out during the quarter.
Bruderman Asset Management sold 2 Microbot Medical shares in Q2 2019.
Bruderman Asset Management first reported a position in Microbot Medical in Q4 2018 and held it in 2 quarters.
Bruderman Asset Management's Microbot Medical position peaked at $0 in Q1 2019.
30 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2019.

Based on Bruderman Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.